Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'

Area of Science:

• Gastroenterology
• Clinical Pharmacology

Background:

• The efficacy of acid-decreasing agents in managing peptic ulcer hemorrhage remains debated.
• Previous clinical trials often involve small patient numbers, limiting definitive conclusions.

Purpose of the Study:

• To conduct a meta-analysis evaluating the effectiveness of acid-decreasing agents in peptic ulcer hemorrhage management.
• To synthesize evidence from randomized placebo-controlled trials to clarify treatment benefits.

Main Methods:

• A systematic literature search identified relevant studies from 1980-1999 in Medline.
• Included studies were randomized, placebo-controlled, and published in English.
• Meta-analysis employed Mantel-Haenszel and blinded random models for statistical analysis.

Main Results:

• Twenty-one trials with 3566 patients were analyzed, assessing H2-antagonists, proton pump inhibitors, and antacids.
• A significant reduction in re-bleeding rates (OR 0.727) and surgery rates (OR 0.707) was observed.
• No significant effect on mortality rates was found (OR 1.140).

Conclusions:

• Acid-decreasing agents offer significant benefits by reducing re-bleeding and surgery rates in acute peptic ulcer hemorrhage.
• Current evidence does not support a mortality benefit from these agents in this patient population.